Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Binocrit

Binocrit 1 000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 2 000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 3 000 IU/0.3 mL solution for injection in a pre-filled syringe Binocrit 4 000 IU/0.4 mL solution for injection in a pre-filled syringe Binocrit 5 000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 6 000 IU/0.6 mL solution for injection in a pre-filled syringe Binocrit 7 000 IU/0.7 mL solution for injection in a pre-filled syringe Binocrit 8 000 IU/0.8 mL solution for injection in a pre-filled syringe Binocrit 9 000 IU/0.9 mL solution for injection in a pre-filled syringe Binocrit 10 000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 20 000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 30 000 IU/0.75 mL solution for injection in a pre-filled syringe Binocrit 40 000 IU/1 mL solution for injection in a pre-filled syringe · Abschnitt 4.8 · PDF-Seite 16–17

HOS-208652 · Präparat HOS-154153

16 MedDRA System Organ Adverse Reaction (Preferred Frequency Classification (SOC) Term Level) peripheral Medicinal product ineffective3 Not known Anti-erythropoietin antibody Investigations Rare positive 1 Common in dialysis 2 Includes arterial and venous, fatal and non fatal events, such as deep venous thrombosis, pulmonary emboli, retinal thrombosis, arterial thrombosis (including myocardial infarction), cerebrovascular accidents (including cerebral infarction and cerebral haemorrhage) transient ischaemic attacks, and shunt thrombosis (including dialysis equipment) and thrombosis within arteriovenous shunt aneurisms 3 Addressed in the subsection below and/or in section 4.4

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.